Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Intercept Pharmaceuticals, Inc.

  Law Offices of Howard G. Smith Announces Investigation on Behalf of
  Investors of Intercept Pharmaceuticals, Inc.

Business Wire

BENSALEM, Pa. -- February 21, 2014

Law Offices of Howard G. Smith announces that it is investigating potential
claims on behalf of investors of Intercept Pharmaceuticals, Inc. (“Intercept”
or the “Company”) (NASDAQ:ICPT) concerning possible violations of federal
securities laws. The investigation focuses on certain statements issued by
Intercept concerning the Company’s operations and financial prospects.

Intercept is a development stage biopharmaceutical company, focused on the
development and commercialization of novel therapeutics to treat chronic liver
diseases utilizing Intercept’s proprietary bile acid chemistry. The Company’s
primary drug compound is obeticholic acid (“OCA”), a bile acid analog that is
in various stages of clinical development for the treatment of cirrhosis and
other chronic liver diseases. The Investigation is related to the Company’s
January 9, 2014, and January 10, 2014, announcements that the Phase 2 clinical
trial of OCA for treatment of non-alcoholic steatohepatitis met its efficacy
endpoint with a high degree of statistical significance.

On January 10, 2014, the National Institutes of Health’s National Institute of
Diabetes and Digestive Kidney Diseases issued a statement that although the
efficacy primary endpoint for OCA had already been met, study participants
suffered disproportionate levels of lipid abnormalities. Following this news,
Intercept stock dropped from its $445.83 per share closing price on January
10, 2014, to a closing price of $255.12 per share on January 14, 2014.

If you purchased Intercept Pharmaceuticals, Inc. securities between January 9,
2014 and January 10, 2014, if you have information or would like to learn more
about these claims, or if you have any questions concerning this announcement
or your rights or interests with respect to these matters, please contact
Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or
visit our website at www.howardsmithlaw.com.

Contact:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
 
Press spacebar to pause and continue. Press esc to stop.